[HTML][HTML] Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes
A Petruzziello, S Marigliano, G Loquercio… - World journal of …, 2016 - ncbi.nlm.nih.gov
METHODS We conducted a systematic study which represents one of the most
comprehensive effort to quantify global HCV epidemiology, using the best available …
comprehensive effort to quantify global HCV epidemiology, using the best available …
Quantitative elastography methods in liver disease: current evidence and future directions
Chronic liver diseases often result in the development of liver fibrosis and ultimately,
cirrhosis. Treatment strategies and prognosis differ greatly depending on the severity of liver …
cirrhosis. Treatment strategies and prognosis differ greatly depending on the severity of liver …
[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017 …
SL James, D Abate, KH Abate, SM Abay, C Abbafati… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and …
2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and …
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a …
GBD Collaborators - 2018 - figshare.le.ac.uk
BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017
(GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years …
(GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years …
[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic …
T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas… - The Lancet, 2017 - thelancet.com
Background As mortality rates decline, life expectancy increases, and populations age, non-
fatal outcomes of diseases and injuries are becoming a larger component of the global …
fatal outcomes of diseases and injuries are becoming a larger component of the global …
[PDF][PDF] Global distribution and prevalence of hepatitis C virus genotypes
JP Messina, I Humphreys, A Flaxman, A Brown… - …, 2015 - Wiley Online Library
Hepatitis C virus (HCV) exhibits high genetic diversity, characterized by regional variations
in genotype prevalence. This poses a challenge to the improved development of vaccines …
in genotype prevalence. This poses a challenge to the improved development of vaccines …
[HTML][HTML] ABT-450/r–ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis
F Poordad, C Hezode, R Trinh… - … England Journal of …, 2014 - Mass Medical Soc
Background Interferon-containing regimens for the treatment of hepatitis C virus (HCV)
infection are associated with increased toxic effects in patients who also have cirrhosis. We …
infection are associated with increased toxic effects in patients who also have cirrhosis. We …
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
BR Edlin, BJ Eckhardt, MA Shu, SD Holmberg… - Hepatology, 2015 - journals.lww.com
Abstract Data from the 2003‐2010 National Health and Nutrition Examination Survey
(NHANES) indicate that about 3.6 million people in the United States have antibodies to the …
(NHANES) indicate that about 3.6 million people in the United States have antibodies to the …
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
Summary Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity
and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct …
and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct …
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
K Gariani, KJ Menzies, D Ryu, CJ Wegner… - …, 2016 - Wiley Online Library
With no approved pharmacological treatment, nonalcoholic fatty liver disease (NAFLD) is
now the most common cause of chronic liver disease in Western countries and its worldwide …
now the most common cause of chronic liver disease in Western countries and its worldwide …